Achillion Pharmaceuticals Inc
ACHN:NASDAQ
| Last | Change / % Change | Dividend Yield | Volume | Avg Volume (10 day) |
| 7.77 | 0.21 2.78% | 0.00% | 823,358 | 675.6K |
Market data is delayed by at least 20 minutes.
Filter SEC Filings
| Filing Type | Filing Date | Category | |||
| 10-Q | May 7, 2013 | Quarterly Financials | |||
| ARS | April 16, 2013 | Annual Report | |||
| DEF 14A | April 12, 2013 | Proxy Statement | |||
| 3 | March 4, 2013 | New Insider | |||
| SC 13G/A | February 26, 2013 | >= 5% Acquisition | |||
| 8-K | February 22, 2013 | Company Events | |||
| 424B2 | February 22, 2013 | Prospectus | |||
| 8-K | February 20, 2013 | Company Events | |||
| 424B5 | February 20, 2013 | Prospectus | |||
| 10-K | February 20, 2013 | Annual Financials | |||
| SC 13G/A | February 14, 2013 | >= 5% Acquisition | |||
| SC 13G/A | February 14, 2013 | >= 5% Acquisition | |||
| 8-K | February 13, 2013 | Company Events | |||
| SC 13D/A | January 18, 2013 | SC 13D/A | |||
| 4 | January 18, 2013 | Insider Buy/Sell | |||
| 4 | January 18, 2013 | Insider Buy/Sell | |||
| 4 | January 18, 2013 | Insider Buy/Sell | |||
| 4 | January 18, 2013 | Insider Buy/Sell | |||
| 4 | January 18, 2013 | Insider Buy/Sell | |||
| 4 | January 18, 2013 | Insider Buy/Sell | |||